endangering patients,” said the FTC's Chair, Lina Khan. “Our inquiry requests information on the factors driving these shortages and scrutinises the practices of opaque drug middlemen.” ...
Evidence also suggests that some of the prescription drug rebates negotiated ... “I’m proud that the FTC launched a bipartisan investigation into these shadowy middlemen, and its preliminary ...
The FTC accuses major PBMs of inflating ... PBMs have long been seen as the “middlemen” getting in the way of lower drug prices, with negotiations often resulting in cheaper products, such ...
The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...